COA2017: IA TXA and IV TXA demonstrate similar results for blood loss in total hip arthroplasty
Intravenous and topical tranexamic acid acid in primary total hip arthroplasty: the tranexamic acid comparison in hip replacement (TeACH-R) ranomized controlled trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
124 patients scheduled for cementless total hip arthroplasty were randomized to be administered either intraarticular tranexamic acid or intravenous tranexamic acid. Patients were assessed for total blood loss, maximum haemoglobin drop, the incidence of transfusion, and the incidence of thromboembolic complications. Results demonstrated no significant differences between groups for either blood lo...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE